Catalyst Wire Dossier Catalyst Wire Dossier

Tacrolimus inhalation powder

Tacrolimus · TFF Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tacrolimus inhalation powder, covering 2025-01-06 to 2025-01-06. Get the full timeline:

Most recent: Clinical Trial Update: An Open Label Trial Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetic Profile of Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients [Phase 2]

See pricing